CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Arman Sabet

OPENALEX: A5071080454↗ORCID: 0000-0002-3469-6638↗

Affiliations

Organizations

Gold Coast Hospitalauthorship · AU Griffith Universityauthorship · AU Indiana University School of Medicineauthorship Neurology, Incauthorship · US

Public evidence

1 connected articles

Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.2019 · PubMed Central Open Access

Registered research

Connected studies

A Randomised, Double-blind, Single-centre Study on the Safety, Tolerability and Efficacy of Cannabis Based Medicine Extract (MediCabilis CBD Oil) in Slowing the Disease Progression in Amyotrophic Lateral Sclerosis or Motor Neurone Disease Patientsnct03690791

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Arman Sabet - Medical Cannabis Research Engine